A first-in-man phase I tolerability and pharmacokinetic study of the cyclin-dependent kinase-inhibitor AZD5438 in healthy male volunteers

By Camidge D.   Smethurst Dominic   Growcott Jim   Barrass Nigel   Foster John   Febbraro Salvatore   Swaisland Helen   Hughes Andrew  

Cancer Chemotherapy and Pharmacology, Vol. 60, Iss. 3, 2007-08 ,pp. : 391-398

Springer Publishing Company

Access to resources Recommend Favorite

A phase I pharmacodynamic study of the effects of the cyclin-dependent kinase-inhibitor AZD5438 on cell cycle markers within the buccal mucosa, plucked scalp hairs and peripheral blood mononucleocytes of healthy male volunteers

By Camidge D.   Pemberton Mike   Growcott Jim   Amakye Dereck   Wilson David   Swaisland Helen   Forder Cheryl   Wilkinson Robert   Byth Kate   Hughes Andrew  

Cancer Chemotherapy and Pharmacology, Vol. 60, Iss. 4, 2007-09 ,pp. : 479-488

Springer Publishing Company

Access to resources Recommend Favorite

First-in-human, phase I dose-escalation study of single and multiple doses of a first-in-class enhancer of fluoropyrimidines, a dUTPase inhibitor (TAS-114) in healthy male volunteers

By Saito Kaku   Nagashima Hirotaka   Noguchi Kazuharu   Yoshisue Kunihiro   Yokogawa Tatsushi   Matsushima Eiji   Tahara Takeshi   Takagi Shigeru  

Cancer Chemotherapy and Pharmacology, Vol. 73, Iss. 3, 2014-03 ,pp. : 577-583

Springer Publishing Company

Access to resources Recommend Favorite

Is the current perception threshold test affected by circadian changes? A study of healthy volunteers

By Tomioka Toshiya   Sawamura Shigehito   Meno Aki   Hayashida Masakazu   Arita Hideko   Hanaoka Kazuo  

The Pain Clinic, Vol. 14, Iss. 3, 2002-09 ,pp. : 213-215

Maney Publishing

Access to resources Recommend Favorite

Male breast cancer: A retrospective study comparing survival with female breast cancer

By        

Oncology Letters, Vol. 4, Iss. 4, 2012-01 ,pp. : 642-646

Spandidos Publications

Access to resources Recommend Favorite